NuGene International Current Valuation vs. Profit Margin
| NUGN Stock | USD 0 0.0009 22.50% |
For NuGene International profitability analysis, we use financial ratios and fundamental drivers that measure the ability of NuGene International to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well NuGene International utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between NuGene International's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of NuGene International over time as well as its relative position and ranking within its peers.
NuGene |
NuGene International Profit Margin vs. Current Valuation Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining NuGene International's current stock value. Our valuation model uses many indicators to compare NuGene International value to that of its competitors to determine the firm's financial worth. NuGene International is rated top company in current valuation category among its peers. It also is considered to be number one stock in profit margin category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value NuGene International by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for NuGene International's Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.NuGene Current Valuation vs. Competition
NuGene International is rated top company in current valuation category among its peers. After adjusting for long-term liabilities, total market size of Shell Companies industry is now estimated at about 3.95 Billion. NuGene International adds roughly 14.83 Million in current valuation claiming only tiny portion of equities listed under Shell Companies industry.
NuGene Profit Margin vs. Current Valuation
Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
NuGene International |
| = | 14.83 M |
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
NuGene International |
| = | (0.11) % |
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
NuGene Profit Margin Comparison
NuGene International is currently under evaluation in profit margin category among its peers.
NuGene International Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in NuGene International, profitability is also one of the essential criteria for including it into their portfolios because, without profit, NuGene International will eventually generate negative long term returns. The profitability progress is the general direction of NuGene International's change in net profit over the period of time. It can combine multiple indicators of NuGene International, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Livento Group, Inc. engages in the film and television production activities. Livento Group, Inc. was incorporated in 2013 and is based in New York, New York. Nugene International operates under Shell Companies classification in the United States and is traded on OTC Exchange. It employs 11 people.
NuGene Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on NuGene International. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of NuGene International position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the NuGene International's important profitability drivers and their relationship over time.
Learn to be your own money manager
Our tools can tell you how much better you can do entering a position in NuGene International without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run ETF Categories Now
ETF CategoriesList of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |
| All Next | Launch Module |
Use Investing Themes to Complement your NuGene International position
In addition to having NuGene International in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Marketing Thematic Idea Now
Marketing
Companies providing marketing and public relation (PR) services as well as news and media distribution. The Marketing theme has 43 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Marketing Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in NuGene Pink Sheet
To fully project NuGene International's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of NuGene International at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include NuGene International's income statement, its balance sheet, and the statement of cash flows.